Astra pulls asthma product, hitting SkyePharma
Reuters L) is ending production of the pressurised metered dose inhaler version of its asthma drug Pulmicort, due to technical problems, in a move that will hit its technology partner SkyePharma (SKP.L). SkyePharma developed the formulation for the medicine … |
View full post on asthma – Google News